P4-362: Brain glucose metabolism in patients with mild to moderate Alzheimer's disease before and after six months treatment with intravenous immunoglobulin (octagam 10%): A phase II double blind, placebo-controlled multi-center study

2011 ◽  
Vol 7 ◽  
pp. e39-e39
Author(s):  
Axel Rominger ◽  
Stefan Foerster ◽  
Christian Zach ◽  
Richard Dodel ◽  
Kaj Blennow ◽  
...  
Keyword(s):  
Glucose Metabolism ◽  
Intravenous Immunoglobulin ◽  
Phase Ii ◽  
Double Blind ◽  
Brain Glucose ◽  
Brain Glucose Metabolism ◽  
Double Blind Placebo ◽  
Before And After ◽  
Multi Center Study ◽  
Center Study

Gabapentin in traumatic nerve injury pain: A randomized, double-blind, placebo-controlled, cross-over, multi-center study

Pain ◽  
2008 ◽  
Vol 138 (2) ◽  
pp. 255-266 ◽  
Author(s):  
Torsten E. Gordh ◽  
Audun Stubhaug ◽  
Troels S. Jensen ◽  
Staffan Arnèr ◽  
Björn Biber ◽  
...  
Keyword(s):  
Nerve Injury ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Multi Center Study ◽  
Center Study

A zinc-containing compound, Polaprezinc, is effective for patients with taste disorders: randomized, double-blind, placebo-controlled, multi-center study

2009 ◽  
Vol 129 (10) ◽  
pp. 1115-1120 ◽  
Author(s):  
Masafumi Sakagami ◽  
Minoru Ikeda ◽  
Hiroshi Tomita ◽  
Akihiro Ikui ◽  
Tsunemasa Aiba ◽  
...  
Keyword(s):  
Double Blind ◽  
Double Blind Placebo ◽  
Taste Disorders ◽  
Multi Center Study ◽  
Center Study

7:423. Oral REN-1654 in Sciatica: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study in Subjects With Pain Due to Lumbosacral Radiculopathy

2006 ◽  
Vol 6 (5) ◽  
pp. 2S ◽  
Author(s):  
Eugene J. Carragee ◽  
Jack A. Klapper ◽  
Michael K. Schaufele ◽  
Jaro Karppinen ◽  
Jon Levine ◽  
...  
Keyword(s):  
Phase 2 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Lumbosacral Radiculopathy ◽  
Multi Center Study ◽  
Center Study
Sign in / Sign up

Export Citation Format

Share Document